You are here: Welcome » UHN Foundation

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
uhn_foundation [2022/05/07 03:36]
liam [Donors]
uhn_foundation [2022/05/15 00:46] (current)
liam [Donors]
Line 9: Line 9:
 ==== Donors ==== ==== Donors ====
  
-UHNF has received in the range of $10-25 million from [[pharmaceutical_companies:Gilead Sciences]] and [[pharmaceutical_companies:Roche]].((//2020/21 Report to Our Donors.// UHN Foundation. Retrieved May 6, 2022, from https://web.archive.org/web/20220507012703/https://uhnfoundation.ca/who-we-are/publications/2020-21-report-to-our-donors/)) Additional multi-million dollar donors include [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Actelion]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:Apotex]], [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[CIBC]], [[medical_technology_Companies:Medtronic]], [[pharmaceutical_companies:Novartis]], the [[RBC Foundation]], [[Scotiabank]], [[Barry Sherman]], [[Honey Sherman]], [[Sun Life Financial]] and [[TD Bank Group]].+UHNF has received in the range of $10-25 million from [[pharmaceutical_companies:Gilead Sciences]] and [[pharmaceutical_companies:Roche]].((//2020/21 Report to Our Donors.// UHN Foundation. Retrieved May 6, 2022, from https://web.archive.org/web/20220507012703/https://uhnfoundation.ca/who-we-are/publications/2020-21-report-to-our-donors/)) Additional multi-million dollar donors include [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Actelion]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:Apotex]], [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Axcan]], [[pharmaceutical_companies:Baxter]], [[pharmaceutical_companies:Bayer]], [[Bell]], [[pharmaceutical_companies:BlueRock Therapeutics]], [[BMO Financial Group]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre for Commercialization of Innovative Medicine]], [[CIBC]], [[pharmaceutical_companies:CymaBay Therapeutics]], [[Deloitte]], [[Ernst & Young]], [[pharmaceutical_companies:GlaxoSmithKline]], [[Imperial Oil]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[KPMG Foundation]], [[Loblaws]], [[pharmaceutical_companies:Lundbeck]], [[Manulife]], [[medical_technology_Companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Otsuka]], [[pharmaceutical_companies:Pfizer]], the [[RBC Foundation]], [[Research Manitoba]], [[Rogers Communications]], [[Scotiabank]], [[Barry Sherman]], [[Honey Sherman]], [[Sun Life Financial]], [[pharmaceutical_companies:Synthes]], [[TD Bank Group]], and the [[University of Toronto]].
Back to top